Leaderboard

En | De
Sie sind hier: Onkologie » Urologische Tumoren 30. April 2026
Suchen
medline.ch
Urologische Tumoren
Erweiterte Suche
Dermatologie
Endokrinologie
Ernährung
Gastroenterologie
Gynäkologie
Hämatologie
Infektiologie
Kardiovaskuläre Erkrankungen
Muskuloskelettale Erkrankungen
Neurologie
Onkologie
Bewegungsapparat
Blut
Endokrine Organe
Gynäkologische Tumoren
Haut
Magen-Darm
ORL
Respirationstrakt
Urologische Tumoren
ZNS
Ophthalmologie
ORL
Pädiatrie
Psychiatrie
Respirationstrakt
Sportmedizin
Urologie-Nephrologie
Schrift: Schrift grösser Schrift kleiner

Rect Top
   Seite 1 von 8894  vorhergehende Seite nächste Seite
   
   Artikel 1 - 20 / 177862  
   
An Integrated Graphene-MXene Electrochemical Transistor Array Platform for Accurate Prostate Cancer Diagnosis Using Plasma sEV-Derived E2F5 Biomarker.
Small
Mukherjee P, Sultana N, Sahu G, Goyal I, Besra L, Das P, Sarkar D, Bishnu D, Sharma P, Sengupta S, Chatterjee S, RoyChaudhuri C.
PMID: 42057744 [PubMed - as supplied by publisher]


Editorial Comment to Real-World Outcomes After Radical Cystectomy for Muscle-Invasive Bladder Cancer in Japan: A Nationwide Descriptive Study From the National Clinical Database.
Int J Urol
Miyake M.
PMID: 42057503 [PubMed - in process]


Editorial Comment to Niraparib With Abiraterone Acetate Plus Prednisone as First-Line Therapy in Patients With Metastatic Castration-Resistant Prostate Cancer With Homologous Recombination Repair Gene Alterations: Final Analysis of the Asian Subgroup From the MAGNITUDE Study.
Int J Urol
Miyazawa Y.
PMID: 42057499 [PubMed - in process]


Metabolic syndrome and risk of kidney cancer in the United States.
Cancer
Jung M, Wang X, Jeon SY, Graff RE, Deng Z, L'Espérance K, Li M, Langston ME, Chung BI.
PMID: 42057471 [PubMed - indexed for MEDLINE]


Comprehensive analysis of ATF3 as a diagnostic and prognostic biomarker from pan-cancer to clear cell renal cell carcinoma.
Discov Oncol
Ling H, Wu G, Hu Y.
PMID: 42056650 [PubMed]


Quality and readability of online penile-cancer information: a Cross-Sectional Web Study.
Int J Impot Res
Ma J, Wang M, Liu Q, Chen Z, Li R, Huang Y, Zhang X.
PMID: 42056491 [PubMed - as supplied by publisher]


Oncological efficacy, functional outcomes and safety of MR-guided ultrasound ablation (MRgFUS/TULSA) for localized prostate cancer: a scoping review.
Radiol Med
Salvaggio G, Midiri F, Gagliardo C, Salerno S, Lupo G, Benfante V, Comelli A, Lo Re G, Galia M, Midiri M.
PMID: 42056384 [PubMed - as supplied by publisher]


Salvage High-intensity Focused Ultrasound for Prostate Cancer Recurrence after Radiotherapy (HIFI-2 Study).
Eur Urol Oncol
Ploussard G, Coloby P, Chevallier T, Occéan BV, Kassab D, Houédé N, Villers A, Rischmann P.
PMID: 42055879 [PubMed - as supplied by publisher]


Quantifying the Heterogeneity of TRUS-Visible Lesions for Predicting Prostate Cancer: A Multicenter Preliminary Study.
Acad Radiol
Zheng B, Zhu J, Xu M, Wu X, Jiang J, Zhang Y, Shen C, Zhang Z, Huang H, Liu X.
PMID: 42055868 [PubMed - as supplied by publisher]


Transcriptome-based Deep Learning Model for Predicting Gemcitabine and Cisplatin Chemotherapy Response in Urothelial Carcinoma: Development and External Validation.
Cancer Genomics Proteomics
Kang J, Lee HJ, Oh SB, Nam JK, Kim TU, Ryu H, Ki YK, Kang J, Kim YR, Lee JH, Choi J, Hong YJ, Park K.
PMID: 42055629 [PubMed - indexed for MEDLINE]


Integrative multi-omics analysis identifies key ubiquitination regulators in prostate cancer.
Transl Oncol
Wei H, Gong C, Tan Z, Yang E, Huang Y, An Y, Li H, Lv D, Yang C, Chen W, Wang H, Li S, Ding M, Wang J.
PMID: 42055487 [PubMed - as supplied by publisher]


HSR26-234: Real-World and Clinical Outcomes of Immunotherapy-Based Regimens Versus Tyrosine Kinase Inhibitor Monotherapy in First-Line Metastatic Papillary Renal Cell Carcinoma: A Systematic Review and Meta-Analysis.
J Natl Compr Canc Netw
Vemula SSM, Kamal F, Fernet L, Afridi S, Shah N, Faheem MSB, Gergis S, Isaac D.
PMID: 42055426 [PubMed - in process]


Liquid Biopsy Biomarkers in Patients With Metastatic Castration-Resistant Prostate Cancer Receiving Prostate-Specific Membrane Antigen Radioligand Therapy: Protocol for a Prospective, Longitudinal Multicenter Observational Study.
JMIR Res Protoc
Michalski K, Lorenzini T, Jedamzik T, Heinrich M, Kosmala A, Rauscher I, Bauch M, Reichl L, Amann L, Liebl S, Buck A, Eiber M, Lapa C, Claus R.
PMID: 42054640 [PubMed - indexed for MEDLINE]


Treatment Patterns and Outcomes in Localized Urothelial Carcinoma in Middle-Income Countries: A Multicenter Real-World Study.
JCO Glob Oncol
Castello Dias Carneiro AP, Batista EC, Gomes Bugano DD, Corradi RG, Panhoca R, Soler JA, Carvalhal E, Ponte de Souza AL, Motke B, Helber HA, Sampaio BDS, Monfardini F, Lamas Assis SR, Rodrigues Sant'Anna VA, Prado Dos Santos G, Lopes da Silva M, Duarte FM, Pereira M, Fagundes Moia DD, Soares RVP, Carneiro A, Perini GF, Rizzo LV, Maluf FC.
PMID: 42054609 [PubMed - indexed for MEDLINE]


International Society of Urological Pathology Consensus on Cancer Precursor Lesions: Working Group 3 Preneoplastic and Precursor Lesions of the Kidney.
Am J Surg Pathol
Williamson SR, Wobker SE, Mehra R, Al-Obaidy KI, Martignoni G, Mohanty S, Smith SC, Tan PH, Tretiakova M, Kapur P, Wu CL, Akgul M, Sangoi AR, Hakimi AA, Shuch B, Brugarolas J, Kristiansen G, Cheng L, Moch H, And the Members of the ISUP GU Cancer Precursor Consensus Panel.
PMID: 42054499 [PubMed - as supplied by publisher]


The emerging role of the microbiome in bladder cancer: prognostic implications and treatment response.
Braz J Med Biol Res
Côrtes J, Trindade Filho JCS, Rogatto SR.
PMID: 42054198 [PubMed - indexed for MEDLINE]


Papillary renal neoplasm with reverse polarity: a novel entity for the next WHO classification? a clinical-pathological and molecular study of 15 cases, compared to eosinophilic/oncocytic papillary renal cell carcinoma.
Virchows Arch
Marletta S, Fiorini D, Caliò A, Marcolini L, Stefanizzi L, Giacometti C, Pedron S, Vicentini C, Martignoni G.
PMID: 42053817 [PubMed - as supplied by publisher]


Bayesian reanalysis of the NIAGARA trial using reconstructed individual patient data: perioperative durvalumab in cisplatin-eligible muscle-invasive bladder cancer.
Jpn J Clin Oncol
Hirose K, Yoshida S, Chen W, Yajima S, Sato H, Hirakawa A, Tanabe K, Fujiwara M, Fukushima H, Yasuda Y, Tanaka H, Masuda H, Fujii Y.
PMID: 42053502 [PubMed - as supplied by publisher]


A Gene Expression Tumor Signature Optimizing Partial Area-Under-the-Curve (pAUC) to Improve Specificity for Indolent Prostate Cancer.
Prostate
Gerke TA, Tyekucheva S, Stopsack KH, Sweeney CJ, Lis RT, Westling EN, Loda M, Stampfer MJ, Penney KL, Parmigiani G, Mucci LA.
PMID: 42053424 [PubMed - as supplied by publisher]


Laparoscopic radical cystectomy in patients with bladder cancer: A modified technique with reduced morbidity - A comparative study.
Urologia
Sharma A, Biswal D, Sharma S, Ravani Thrilochana R, Yadav P, Goel S, Alam P.
PMID: 42053413 [PubMed - as supplied by publisher]


   
   Artikel 1 - 20 / 177862    Seite 1 von 8894  vorhergehende Seite nächste Seite

 
Rect Bottom
Adserver Footer
 

Suchbegriffe

Benutzen Sie englische Suchbegriffe für Ihre Suche in medline.ch.

 

Übersetzungsproblem?

mehr >>

  Zeitfenster  
   

Sky right 1